首页> 外文期刊>The International journal of risk & safety in medicine. >Adverse reactions: Safety of the long-acting beta_2-agonist salmeterol in patients with severe bronchial obstruction
【24h】

Adverse reactions: Safety of the long-acting beta_2-agonist salmeterol in patients with severe bronchial obstruction

机译:不良反应:长效β_2-激动剂沙美特罗在严重支气管阻塞患者中的安全性

获取原文
获取原文并翻译 | 示例
       

摘要

Salmeterol is a selective beta_2-stimulant claimed to have long-lasting (>12 hrs) relaxant effects on bronchial smooth muscle. Due to widespread suspicion of tachyphylaxis induced by such agents [1-4] and some evidence that they might be misused [5], all individuals given this drag in Norway were registered during the years 1992-94 when salmeterol was first introduced onto the market.
机译:沙美特罗是一种选择性的β_2刺激剂,据称对支气管平滑肌具有持久(> 12小时)的松弛作用。由于广泛怀疑此类药物引起的速激肽[1-4],以及一些可能被滥用的证据[5],因此在挪威受此药物拖累的所有个人均在1992-94年间首次注册沙美特罗上市。 。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号